Objective-There are currently no specific strategies for the treatment or prevention of vascular dementia. White matter lesions, a common pathology in cerebral small vessel disease, are a major cause of vascular dementia. We investigated whether apoptosis signal-regulating kinase 1 (ASK1) might be a key molecule in cerebral hypoperfusion, associated with blood-brain barrier breakdown and white matter lesions. Approach and Results-A mouse model of cognitive impairment was developed by inducing chronic cerebral hypoperfusion in white matter including the corpus callosum via bilateral common carotid artery stenosis (BCAS) surgery. BCASinduced white matter lesions caused cognitive decline in C57BL/6J (wild-type) mice but not in ASK1-deficient (ASK1 −/− ) mice. Phosphorylated ASK1 increased in wild-type mouse brains, and phosphorylated p38 and tumor necrosis factor-α expression increased in corpus callosum cerebral endothelial cells after BCAS in wild-type mice but not in ASK1 −/− mice. BCAS decreased claudin-5 expression and disrupted blood-brain barrier in the corpus callosum of wild-type but not ASK1 −/− mice. Cerebral nitrotyrosine was increased in wild-type and ASK1 −/− BCAS mice. Cerebral phosphorylated ASK1 did not increase in wild-type mice treated with NADPH-oxidase inhibitor. A p38 inhibitor and NADPH-oxidase inhibitor mimicked the protective effect of ASK1 deficiency against cognitive impairment. Specific ASK1 inhibitor prevented cognitive decline in BCAS mice. In vitro oxygen-glucose deprivation and tumor necrosis factor-α stimulation caused the disruption of endothelial tight junctions from wild-type mice but not ASK1 −/− mice. Conclusions-Oxidative stress-ASK1-p38 cascade plays a role in the pathogenesis of cognitive impairment, through bloodbrain barrier breakdown via the disruption of endothelial tight junctions. ASK1 might be a promising therapeutic target for chronic cerebral hypoperfusion-induced cognitive impairment. (Arterioscler Thromb Vasc Biol. 2014;34:616-625.) The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
I n developed countries, the number of dementia cases is increasing as the population ages, causing the financial cost of dementia to increase. 1 Vascular dementia (VaD) is the second most common cause of dementia after Alzheimer disease 2 and is characterized by white matter (WM) lesions. 3 The cause and development of WM lesions are not fully understood. Cerebral microangiopathies, one major cause of VaD, are detected using MRI and histopathologic examinations or assays. 4 Histologically, cerebral microangiopathy is characterized by vascular wall thickening, collagen deposition, degeneration of smooth muscle cells, and narrowing of the lumen; it is often associated with blood-brain barrier (BBB) breakdown. 4 Although the association between VaD and Alzheimer disease is most likely caused by the interplay of common and shared vascular risk factors possibly leading to a vascular drainage failure of β-amyloid, cerebrocapillary damage caused by cerebral hypoperfusion might also contribute to the progression of Alzheimer disease. [5] [6] [7] Despite the high level of need, there are currently no effective strategies for the treatment or prevention of VaD. Therefore, the precise mechanism of VaD and the development of a clinical therapeutic strategy for VaD are urgent topics for research.
Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen-activated protein (MAP) kinase kinase kinase family, activates MAP kinase kinases, which in turn activate p38 and C-Jun N-terminal (JNK) MAP kinase. 8 
ASK1 plays
a key role in cellular responses induced by a variety of stressors including oxidative stress 9 (Figure I in the online-only Data Supplement). Our previous reports showed that ASK1 is involved in angiotensin II-induced vascular endothelial dysfunction and apoptosis, 10 balloon injury-induced vascular neointima formation, 11 and ischemia-induced angiogenesis. 12 The potential role of ASK1 in cerebral vasculature/small vessels should be further investigated in relation to VaD. Cerebral ischemia increases cerebral oxidative stress levels 13 and vascular cognitive impairment induced by chronic cerebral ischemia is associated with BBB disruption. [14] [15] [16] The BBB consists of endothelial cells, basal lamina matrix, astrocyte end-feet, and pericytes. Therefore, in the present study, we hypothesized that ASK1 might be involved in oxidative stress-induced BBB disruption because of cerebral endothelial cell dysfunction and thereby might be responsible for chronic cerebral hypoperfusion-induced WM lesions and cognitive impairment.
The rat model of chronic cerebral hypoperfusion induced by bilateral common carotid artery occlusion is characterized by WM rarefaction and is widely used as a VaD model. 17 However, accurate behavioral assessment of this rat model is often hampered by loss of the visual pathway caused by occlusion of the ophthalmic arteries. Therefore, in the present study, we used a mouse model of cognitive impairment, produced by bilateral common carotid arterial stenosis (BCAS) with microcoils. 13, 18, 19 This model develops mild damage to the visual pathway and maintains a residual blood flow within the common carotid arteries and branches, such as the ophthalmic arteries, 19 because BCAS surgery in mice induces a milder decrease in the cerebral blood flow than bilateral common carotid artery occlusion in rats. Pathology of the BCAS mouse model is characterized commonly by memory deficits with WM lesions and BBB breakdown. 13, 16, 19 This study examined the effects of BCAS surgery on cognitive function, WM pathology, and BBB function between C57BL/6J wild-type mice and ASK1-deficient (ASK1 −/− ) mice and also investigated the effects of a specific ASK1 inhibitor in BCAS mice.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Role of ASK1 in a Mouse Model of Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion
BCAS surgery significantly and equally lowered cerebral blood flow of C57BL/6J wild-type mice and ASK1 −/− mice at To evaluate the role of ASK1 in cognitive function, we performed Y-maze tests, Morris water maze tests, fixed and progressive ratio tasks, and novel object recognition tests on wild-type mice and ASK1 −/− mice subjected to BCAS surgery. Consistent with previous reports, 13, 18 mice subjected to sham versus BCAS surgery did not show significant differences in locomotor activity. In the Y-maze test, there was no significant difference in the number of arm entries among all groups, indicating no change in motor performance ( Figure 1A ). However, compared with sham surgery, BCAS surgery caused significant cognitive decline in wild-type mice but not in ASK1 −/− mice ( Figure 1B ).
In the Morris water maze test, wild-type mice subjected to BCAS surgery had severe learning deficits in the hidden platform test compared with sham, whereas ASK1 −/− mice subjected to BCAS did not exhibit any learning impairment ( Figure 1C ). In the probe test, only wild-type mice subjected to BCAS surgery demonstrated significantly poor performance, although the other groups crossed over the previous platform location ( Figure 1D ). In the visible test, there were no significant differences in escape time among all groups, indicating that visual function was similar between them ( Figure 1E ).
In the fixed ratio tasks evaluated by the operant chamber, as the fixed rate of lever presses increased, from rate 1 to 3, the mean response times of wild-type mice subjected to BCAS surgery tended to decrease to a lesser extent than the other 3 groups ( Figure IIIA -IIIC in the online-only Data Supplement). As shown in Figure 1F , there were significantly poor responses for fixed lever presses at rate 4 in wild-type BCAS mice, whereas ASK1 −/− BCAS mice showed good responses similar to both sham groups. In the progressive ratio tasks, the mean lever presses at the break point of wild-type BCAS mice were significantly lower than in the other groups ( Figure 1G ).
In the novel object recognition test, there were no significant differences in the exploratory preferences at the baseline among all groups ( Figure IIID in the online-only Data Supplement), and there was no significant difference in the exploratory preferences toward the novel object among the 4 experimental groups ( Figure IIIE in the online-only Data Supplement).
To evaluate anxiety-like responses, we also performed the light and dark test because cognition is strongly affected by motivational and emotional features. BCAS surgery did not affect anxiety-like responses in wild-type or ASK1 −/− mice ( Figure IIIF and IIIG in the online-only Data Supplement), which is consistent with a previous report using the same mouse model. 18 It was shown that cognitive dysfunction in this mouse model was because of WM lesions and astrocyte activity. 19 To confirm cognitive decline was a result of the difference in WM lesions and glial activation, we evaluated the WM lesion grades and counted astrocyte cells in the corpus callosum as previously described. 13 Interestingly, BCAS surgery caused significant increases in WM lesions ( Figure 1H ) and activation of astrocytes ( Figure 1I ) in wild-type mice but not in ASK1 -/mice. As shown in Figure IVA to IVC in the online-only Data Supplement, wild-type mice subjected to BCAS with 0.16-mm microcoils, but not 0.18-mm microcoils, demonstrated reference memory decline as previously reported. 19 Importantly, mice treated with 0.16-mm microcoils had lower cerebral blood flow than those with 0.18-mm microcoils ( Figure IVD and IVE in the online-only Data Supplement), suggesting that the significant difference in reference memory between mice with 0.16-and 0.18-mm microcoils might be partially because of the difference in cerebral blood flow. As shown in Figure IVF in the online-only Data Supplement, the mortality rate of BCAS mice treated with 0.16-mm microcoils was 37.5% (6/16) within 14 days after surgery, whereas that of BCAS mice treated with 0.18-mm microcoils was 0% (0/10). The mortality rate (37.5%) of our BCAS model with 0.16-mm microcoils was less than that (75%) reported in the previous article by Shibata et al. 19 This difference in mortality rate between our present work and previous study 19 can be possibly explained by the difference in animal age, body weight, anesthesia (isoflurane in our work versus pentobarbital in the previous article), 19 or operator.
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Effect of Cerebral Hypoperfusion on ASK1 and Its Downstream Molecules
We next examined the effect of cerebral hypoperfusion induced by BCAS surgery on the induction of ASK and its downstream molecules, p38 and C-Jun N-terminal kinase. Interestingly, phosphorylation of ASK1 and p38 increased persistently in wild-type mouse brain tissue after BCAS surgery, but p38 phosphorylation did not increase persistently in ASK1 −/− mice (Figure 2A and 2B). In contrast, BCAS surgery did not affect C-Jun N-terminal kinase phosphorylation in both strains of mice ( Figure 2C ). To identify the site of cellular activation of phosphorylated p38, we performed double immunofluorescent staining of phosphorylated p38 with cerebral endothelial cells (CD31), oligodendrocytes (GSTpi), astrocytes, and microglia in the corpus callosum of both strains of BCAS mice at 30 minutes. Phosphorylated p38 was localized in the 
Role of ASK1 in BBB and Cerebral Tight Junctions
BCAS surgery caused significant BBB disruption in the corpus callosum of wild-type mice but not in ASK1 −/− mice, as evaluated by Evans blue leakage from cerebral endothelial cells ( Figure 3A ). BBB breakdown is involved in the dysfunction of the neurovascular unit: the endothelial cell-basal lamina matrix-astrocyte end-feet and pericytes. 20 BCAS surgery did not alter cerebral matrix metalloproteinase activity evaluated by zymography ( Figure VIA in the online-only Data Supplement), indicating no effect of cerebral hypoperfusion on the basal lamina matrix in brains of both strains of mice. Aquaporin-4 has an important role in the transport of water through the cell membrane of astrocyte end-feet and is associated with brain edema as a result of BBB dysfunction after cerebral ischemia. 21 In the present study, changes in aquaporin-4 levels were not observed in brains from both strains of mice after BCAS surgery at early stages ( Figure VIB in the online-only Data Supplement). However, BCAS surgery significantly decreased the expression of claudin-5 in the corpus callosum of wild-type mice but not in ASK1 −/− mice ( Figure 3B ). As shown in Figure 3C , Evans blue leakage was observed with decreased claudin-5 expression in the corpus callosum of wild-type BCAS mice.
Effect of Cerebral Hypoperfusion on Tumor Necrosis Factor-α
Cerebral mRNA levels of tumor necrosis factor-α (TNF-α) increased from 24 hours ( Figure 3D ) to 4 weeks (data are not shown) after BCAS surgery in wild-type mice but not in ASK1 −/− mice. As shown in Figure 3E , BCAS surgery significantly increased TNF-α levels in the brain of wild-type mice at 72 hours but not in ASK1 −/− mice. The active form of TNF-α was expressed in the cerebral endothelial cells of wild-type BCAS mice at 72 hours ( Figure 3F ).
Effect of Cerebral Hypoperfusion on Oxidative Stress
To evaluate the effect of cerebral hypoperfusion on oxidative stress, we measured cerebral nitrotyrosine levels. Interestingly, cerebral nitrotyrosine after BCAS surgery significantly increased from 10 minutes in wild-type mice and ASK1 −/− mice ( Figure 4A ). We next evaluated the effect of apocynin, a NADPH-oxidase inhibitor, on the phosphorylation of ASK1 and p38 after cerebral hypoperfusion. As shown in Figure 4B and 4C, treatment of apocynin significantly prevented the induction of phosphorylated ASK1 and p38 in the brains of mice subjected to BCAS surgery, indicating that oxidative stress was upstream of ASK1.
In Vitro Effect of Oxygen-Glucose Deprivation on Cerebral Tight Junctions
To investigate the contribution of hypoxia conditions in the disruption of cerebral endothelial tight junctions, we used primary cultures of mouse cerebral endothelial cells from wild-type and ASK1 −/− mice. Oxygen-glucose deprivation conditions decreased expression of cerebral tight junction integral membrane protein claudin-5 and occludin in wild-type mouse cerebral endothelial cells, but not in ASK1 −/− mouse cells ( Figure 4D-4G ).
In Vitro Effect of TNF-α Stimulation on Cerebral Tight Junctions
To investigate the contribution of TNF-α to the disruption of cerebral tight junctions, primary cultures of mouse cerebral endothelial cells from wild-type and ASK1 −/− mice were isolated. In vitro, TNF-α stimulation significantly decreased claudin-5 and occludin in cerebral endothelial cells from wild-type mice but not ASK1 −/− mice ( Figure VIIIA -VIIID in the online-only Data Supplement). To confirm whether TNF-α existed upstream and downstream of ASK1, the effect of TNF-α stimulation on phosphorylated ASK1 in cerebral cells from wild-type mice was evaluated. Phosphorylation of ASK1 was increased significantly in cerebral endothelial cells from wild-type mice at 10 minutes after TNF-α stimulation ( Figure VIIIE in the online-only Data Supplement). This finding indicated TNF-α is a key mediator of the vicious cycle in the ASK1/TNF-α pathway.
Role of p38 and Oxidative Stress in BBB Dysfunction and Cognitive Impairment
We next investigated the role of p38 and oxidative stress in BBB dysfunction and cognitive impairment. BCAS surgery significantly and equally lowered cerebral blood flow in wild-type mice treated with vehicle or SB239063 (a specific p38 inhibitor) or apocynin ( Figure 5A and 5B ). There was no significant difference in blood pressure ( Figure 5C ) or the number of arm entries among all groups ( Figure 5D ). Treatment with SB239063 and apocynin prevented cognitive decline ( Figure 5E ), WM lesions ( Figure 5F ), activation of astrocytes ( Figure 5G ), and the induction of cerebral mRNA levels of TNF-α ( Figure 5H ) in wild-type BCAS mice. As shown in Figure 5I , BCAS surgery failed to disrupt the BBB in wild-type mice treated with SB239063 and apocynin.
Treatment With Compound K811, ASK1 Selective Inhibitor, on Cognitive Impairment Induced by Cerebral Hypoperfusion
BCAS surgery significantly and equally lowered cerebral blood flow in wild-type mice treated with vehicle and those pretreated with compound K811 (Figure 6A and 6B ). There was no significant change in blood pressure ( Figure 6C ) or in the number of arm entries ( Figure IXA and IXB in the online-only Data Supplement) among all groups. Interestingly, pretreatment with compound K811 prevented cognitive decline ( Figure 6D and Figure IXC in the online-only Data Supplement), WM lesions ( Figure 6E ), activation of astrocytes ( Figure 6F) , and the induction of cerebral TNF-α mRNA ( Figure 6G ) in wild-type BCAS mice. Postsurgery administration of compound K811 also prevented cognitive decline in wild-type BCAS mice ( Figure XA and XB in the online-only Data Supplement).
Discussion
In the present study, we investigated the role of ASK1 in cognitive impairment and the effect of compound K811, a specific ASK1 inhibitor, on cognitive decline. The major findings of this study were as follows: (1) the oxidative stress-ASK1-p38 pathway is involved in chronic cerebral hypoperfusioninduced WM lesions and cognitive impairment, through BBB breakdown via the disruption of cerebral endothelial tight junctions; and (2) compound K811 prevented cognitive decline in the BCAS mouse model by a similar mechanism to that in ASK1 −/− mice. ASK1 deficiency or inhibition of ASK1 using a pharmacological agent attenuated the severity of cerebral hypoperfusion-induced cognitive impairment, highlighting the ASK1 signaling pathway as a potential therapeutic target during cognitive impairment. Cerebrovascular WM lesions caused by chronic cerebral ischemia are observed in aging and stroke and are responsible for subcortical VaD. 22 To evaluate the role of ASK1 in cerebral hypoperfusion-induced cognitive impairment, we used an established BCAS mouse model, in which chronic cerebral ischemia causes disruption of the BBB. 16, 19 In the present study, we evaluated cognitive impairment using the following behavior tests: Y-maze test, water maze test, fixed and progressive tasks, and novel object recognition tests. Cognitive impairment in this mouse model was characterized by deficits of spatial working memory (Y-maze test), learning and reference-/ working-memory (water maze test), and sensorimotor learning and memory (fixed and progressive tasks), whereas ASK1 deficiency eliminated the development of cognitive impairment. These results suggest the BCAS model is characterized by WM lesions and hippocampal injury. However, BCAS surgery did not affect novel object recognition, suggesting that the perirhinal cortex might not be injured. Thus, BCAS surgery mainly causes WM lesions and hippocampal injury. Previous reports indicated that the rat model of chronic cerebral hypoperfusion also developed working-memory and reference-memory deficits. 5, 23 Therefore, the characteristics of our mouse BCAS model were similar to those of the rat model. In contrast, previous reports by 2 different groups showed reference memory was not impaired in BCAS mice with 0.18-mm internal diameter microcoils. 18, 24 However, our BCAS model was prepared with 0.16-mm internal diameter microcoils. In the present study, we confirmed that BCAS mice treated with 0.18-mm microcoils did not exhibit reference memory decline, in agreement with previous reports. 18, 24 Importantly, BCAS mice treated with 0.16-mm microcoils had less cerebral blood flow than those with 0.18-mm microcoils, suggesting that the significant difference in reference memory observed with different size microcoils might be partially because of the difference in cerebral blood flow. Furthermore, the anxiety response was not affected by chronic cerebral hypoperfusion in either wild-type or ASK1 −/− mice, thereby excluding the possibility that cognitive function might be affected by motivational and emotional features.
A neurovascular unit consists of microvessels (endothelial cells-basal lamina matrix-astrocyte end-feet, and pericytes), astrocytes, neurons and their axons, in addition to other cell types (microglia and oligodendrocytes). 20 BBB breakdown is involved in the dysfunction of the neurovascular unit. Compared with neurons, cerebral microvessels are more susceptible to cell injury after brain ischemia. 20 In the present study, cerebral oxidative stress levels were increased in mice subjected to BCAS surgery, as previously reported. 25 NADPH oxidase is a major enzyme-producing superoxide (oxidative stress) and is significantly increased in cerebral tissue of BCAS mice. 13 Therefore, we investigated the involvement of oxidative stress in ASK1-mediated cerebral hypoperfusioninduced cognitive impairment by administering apocynin, an NADPH-oxidase inhibitor, to BCAS surgery. ASK1 was activated by oxidative stress caused by cerebral hypoperfusion. Furthermore, to determine whether p38, a downstream molecule of ASK1, contributed to cognitive impairment induced by cerebral hypoperfusion, we examined the effect of a specific p38 inhibitor in this model. p38 inhibition mimicked the protective effect of ASK1 deficiency against cerebral hypoperfusion-induced cognitive impairment. Collectively, our observations demonstrate that the oxidative stress-ASK1-p38 pathway is involved in the pathogenesis of cerebral hypoperfusion-induced cognitive impairment.
Cerebral endothelial tight junction proteins, such as claudin-5, play a critical role in maintenance of the BBB. Campbell et al 26, 27 used claudin-5 siRNA to demonstrate that claudin-5 has a major role in BBB in mice. In the present study, the BBB was disrupted by decreased claudin-5 in the corpus callosum of WM via the ASK1-p38 signaling pathway during the early stages after cerebral hypoperfusion. To reproduce hypoperfusion-induced BBB breakdown in vitro, we examined the effect of oxygen-glucose deprivation conditions on cultured mouse cerebral endothelial cells. Oxygen-glucose deprivation conditions significantly reduced claudin-5 and occludin in endothelial cells from wild-type mice but not ASK1 −/− mice, thus confirming that hypoperfusion itself is involved in BBB disruption via ASK1.
During focal ischemia, cytokines such as TNF-α are significantly generated and secreted by cells within and around the injured area. 28, 29 The importance of TNF-α on BBB disruption caused by cerebral infarct was reported previously. 30 However, the mechanism of BBB breakdown by TNF-α is not fully understood. In the present study, BCAS surgery significantly increased the cerebral endothelial active form of TNF-α via the ASK1-p38 signaling pathway in the corpus callosum, thereby supporting the idea that TNF-α may disrupt tight junctions via the ASK1-p38 signaling pathway. To elucidate the role of TNF-α in BBB disruption, we compared the effect of TNF-α between cerebral endothelial cells from wild-type mice and ASK −/− mice. Interestingly, in vitro, TNFα stimulation of cerebral endothelial cells from wild-type mice caused both activation of ASK1 and significant disruption of cerebral endothelial tight junctions attributed to a decrease in claudin-5 and occludin. In contrast, TNF-α stimulation failed to disrupt cerebral endothelial tight junctions in ASK1 −/− mice. Collectively our results show that the ASK1-p38-TNF-α pathway is involved in the disruption of tight junctions in the early stages after chronic cerebral hypoperfusion.
Recent studies showed compound K811, a specific ASK1 inhibitor, had a beneficial effect on glial cell activation in experimental autoimmune encephalomyelitis 31 and gastric cancer cell growth in vitro and in vivo. 32 In the present study, administration of compound K811 mimicked the protective effects of ASK1 deficiency in the BCAS mice model. Furthermore, the mechanisms underlying protection against cognitive impairment induced by cerebral hypoperfusion were similar between compound K811 and ASK1 −/− mice. Of note, the postischemic administration of compound K811 also prevented cognitive decline in wild-type mice subjected to BCAS surgery. Our present work indicated that ASK1 might be a novel target molecule for the treatment of cerebral hypoperfusion-induced cognitive impairment. However, further study is required to translate our present experimental data into clinical settings.
There were several limitations in this study. First, macroangiopathic changes such as BCAS surgery are not common causes of VaD. Although appropriate animal models should be selected for each investigation, there are no complete models that include all the features of human VaD. 4 Second, although cerebral microangiopathy and BBB breakdown are seen in histopathologies of vascular cognitive impairment, WM lesions are not necessarily associated with BBB breakdown. Thus, the potential role of BBB disruption in the pathogenesis of VaD remains to be fully determined. Finally, BCAS mice with 0.16-mm microcoils displayed a significant decline of Y-maze and water maze performances, indicating that the BCAS model is characterized by hippocampal injuries and WM lesions. However, histological assessment of hippocampus was not performed, thus further investigation is required to define the characteristics of the BCAS model used in this study.
In conclusion, this study provides the first evidence that the oxidative stress-ASK1-p38 cascade has a pivotal role in the pathogenesis of chronic cerebral hypoperfusion-induced cognitive impairment and WM lesions, through BBB breakdown via the disruption of endothelial tight junctions ( Figure XI in the online-only Data Supplement). We also demonstrated that an ASK inhibitor prevented cognitive decline in BCAS mice. We propose that ASK1 could be a potential novel target for the treatment of cognitive impairment induced by chronic cerebral hypoperfusion.
